191
Participants
Start Date
January 6, 2014
Primary Completion Date
April 13, 2015
Study Completion Date
September 21, 2017
Percutaneous Coronary Intervention
"Implanting a device (Xience Xpedition stent or Abbott Vascular ABSORBTM everolimus eluting bioresorbable vascular scaffold system (BVS) to open a diseased coronary artery by going to the coronary artery subcutaneously through the arteries from the radial or femoral artery access point."
Research centre Aarhus, DK003, Aarhus
Research centre Odense, DK002, Odense
Research centre Leeuwarden, NL002, Leeuwarden
Research centre Nieuwegein, NL014, Nieuwegein
Research centre Barcelona, ES001, Barcelona
Research centre Barcelona, ES003, Barcelona
Research centre Vigo, ES004, Vigo
Research centre Bern, CH006, Bern
Collaborators (1)
Abbott Medical Devices
INDUSTRY
Terumo Europe N.V.
INDUSTRY
ECRI bv
INDUSTRY